# A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma

> **NCT01025206** · PHASE1 · COMPLETED · sponsor: **BioInvent International AB** · enrollment: 35 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** BI-505

## Key facts

- **NCT ID:** NCT01025206
- **Lead sponsor:** BioInvent International AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2013-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025206, "A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01025206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*